Acquired factor V inhibitors: A systematic review

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 4, 2011, Pages 449-457

  Franchini, Massimo ^a   Lippi, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Autoantibodies; Bleeding; FV inhibitors; Therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; PROTHROMBIN COMPLEX; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RITUXIMAB; STREPTOMYCIN; TETRACYCLINE DERIVATIVE; THROMBIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING INHIBITOR;

ACQUIRED FACTOR V INHIBITOR; AUTOIMMUNE DISEASE; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BRAIN HEMORRHAGE; DRUG MEGADOSE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HEMATURIA; HEMOPHILIA A; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SOLID TUMOR; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; ANIMAL; BLEEDING; BLOOD; CATTLE; DRUG ANTAGONISM; METABOLISM;

ANIMALS; BLOOD COAGULATION FACTOR INHIBITORS; CATTLE; FACTOR V; HEMORRHAGE; HUMANS;

EID: 80051795373     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-010-0529-6     Document Type: Review

References (91)

1. Knoble P, Lechner K (1998) Acquired factor V inhibitors. Bailliere's Clin Haematol 11:305-318 (Pubitemid 29103546)
2. Emori Y, Sakugawa M, Niiya K et al (2002) Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. Blood Coagul Fibrinolysis 13:555-559
3. Wiwanitkit V (2006) Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases. Clin Appl Thromb Hemost 12:485-488 (Pubitemid 44359247)
4. Morris CJ, Curris N (2009) Acquired factor V inhibitor in a critically ill patient. Anaesthesia 64:1014-1017
5. Franchini M, Gandini G, Di Paolantonio T et al (2005) Acquired hemophilia A: a concise review. Am J Hematol 80:55-63 (Pubitemid 41254270)
6. Franchini M, Targher G, Montagnana M, Lippi G (2008) Laboratory, clinical and therapeutic aspects of acquired hemophilia A. Clin Chim Acta 395:14-18
7. Ortel T (1999) Clinical and laboratory manifestations of antifactor V antibodies. J Lab Clin Med 133:326-334 (Pubitemid 29373029)
8. Favaloro EJ, Bonar R, Duncan E et al (2006) Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost 96:73-78 (Pubitemid 44160873)
9. Favaloro EJ, Posen J, Ramakrishna R et al (2004) Factor V inhibitors: rare or not so uncommon? A multilaboratory investigation. Blood Coagul Fibrinolysis 15:637-647 (Pubitemid 39612969)
10. Miesbach W, Voigt J, Peetz D, Scharrer I (2003) Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin. Med Klin 98:339-343 (Pubitemid 36806752)
11. Lucia JF, Aguilar C (2005) A case of an asymptomatic idiopathic inhibitor to coagulation factor V. Haemophilia 11:178-180 (Pubitemid 40468068)
12. Takahashi H, Fuse I, Abe T, Yoshino N, Aizawa Y (2003) Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagul Fibrinolysis 14:87-93 (Pubitemid 36206729)
13. Koyama JA, Saito T, Kusano T, Hirosawa S (1995) Factor V inhibitor associated with Sjogren's syndrome. Br J Haematol 89:893-896
14. Streiff MB, Ness PM (2002) Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 42:18-26
15. Banninger H, Hardegger T, Tobler A et al (1993) Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 85:528-532 (Pubitemid 23349056)
16. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH (2001) Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233:88-96 (Pubitemid 32043608)
17. Lu L, Liu Y, Wei J, Zhang L, Yang R (2004) Acquired inhibitor of factor V: first report in China and literature review. Haemophilia 10:661-664 (Pubitemid 39317776)
18. Leus B, Devreese K, Van den Bossche J, Malfait R (2006) Factor V inhibitor: case report. Blood Coagul Fibrinolysis 17:585-587 (Pubitemid 44434972)
19. Kajitani M, Ozdemir A, Aguinaga M, Jazieh AR, Flick JT, Antakli T (2000) Hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product. J Card Surg 15:378-382 (Pubitemid 32977991)
20. Bowman LJ, Anderson CD, Chapman WC (2010) Topical recombinant human thrombin in surgical hemostasis. Semin Thromb Hemost 36:477-484
21. Ang AL, Kuperan P, Ng CH, Ng HJ (2009) Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost 101:852-859
22. Feinstein DI (1978) Acquired inhibitors of factor V. Thromb Haemost 39:663-674 (Pubitemid 9016359)
23. Ferguson JH, Johnston CL, Howell DA (1958) A circulating inhibitor (anti-AcG) specific for the labile factor-V of the bloodclotting mechanism. Blood 13:382-397
24. Lopez V, Pflughaupt R, Butler R (1968) A specific inhibitor of human clotting factor V. Acta Haematol 40:275-285
25. Hundley DA, Duncan BM (1969) A circulating anticoagulant specific for factor V. Pathology 1:265-272
26. Feinstein DI, Rapaport SI, McGehee WG, Patch MJ (1970) Factor V anticoagulants: clinical, biochemical and immunological observations. J Clin Invest 49:1578-1588
27. Feinstein DI, Rapaport SI, Chong MMY (1973) Factor V inhibitor: report of a case, with comments on a possible effect of streptomycin. Ann Intern Med 78:385-388
28. Onuora CA, Lindenbaum J, Nossel HL (1973) Massive hemorrhage associated with circulating antibodies to factor V. Am J Med Sci 265:407-417
29. Nilsson IM, Hedner U, Ekberg M, Denneberg T (1974) A circulating anticoagulant against factor V. Acta Med Scand 195:73-77
30. Stenbjerg S, Husted S, Mygind K (1975) A circulating factor V inhibitor: possible side effect of treatment with strepromycin. Scand J Haematol 14:280-285
31. Crowell EB (1975) Observations on a factor V inhibitor. Br J Haematol 29:397-404
32. Bryning K, Leslie J (1977) Factor V inhibitor and bullous pemphigoid. Br Med J 2:677-678 (Pubitemid 8174252)
33. Coots MC, Muhleman AF, Glueck HI (1978) Hemorrhagic death associated with a high titer factor V inhibitor. Am J Hematol 4:193-206 (Pubitemid 8371096)
34. Lane TA, Shapiro SS, Burka ER (1978) Factor V antibody and disseminated intravascular coagulation. Ann Intern Med 89:182-185 (Pubitemid 9006078)
35. Lust A, Bellon A (1978) A circulating anticoagulant against factor V. Acta Clin Belg 33:62-65 (Pubitemid 9008734)
36. Chediak J, Ashenhurst JB, Garlick I, Desser RK (1980) Sucessful management of bleeding in a patient with factor V inhibitor by platelet transfusion. Blood 56:835-841 (Pubitemid 11242976)
37. Abe T, Kazama M, Itokazu K et al (1980) A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII bypassing activity preparation FEIBA. Rinsho Ketsueki 21:1664-1673
38. Hida K, Sakamoto S, Takaku F et al (1980) A case of acquired coagulopathy due to factor V inhibitor. Rinsho Ketsueki 21:1589-1596 (Pubitemid 12071266)
39. Lerolle D, Dreyer-Dufer C, Allain JP (1981) A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study. Nouv Presse Med 10:1483-1487 (Pubitemid 11105573)
40. Kuto M, Izuchi Y, Deguchi K, Morito T, Lee C, Wada H (1981) An inhibitor against factor V occurring postoperatively in a case of pancreatic cancer. Nippon Ketsueki Gakkai Zasshi 44:938-950 (Pubitemid 11055758)
41. Vickars LM, Coupland RW, Naiman SC (1985) The response of an acquired factor V inhibitor to activated factor IX concentrate. Transfusion 25:51-53 (Pubitemid 15135005)
42. Chong LL, Wong YC (1985) A case of factor V inhibitor. Am J Hematol 19:395-399
43. Chiu HC, Rao AK, Beckett C, Colman RW (1985) Immune complexes containing factor V in a patient with an acquired neutralizing antibody. Blood 65:810-818 (Pubitemid 15115505)
44. Nesheim ME, Nichols WL, Cole TL et al (1986) Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 77:405-415 (Pubitemid 16037638)
45. Brandt J, Britton A, Kraut E (1986) A spontaneous factor V inhibitor with unexpected laboratory features. Arch Pathol Lab Med 110:224-227 (Pubitemid 16144942)
46. Lazarchick J, Wolff M, Pepkowitz SH, Kizer J, Romein LA (1986) Factor V inhibitor associated with immune complex formation. Arch Pathol Lab Med 110:448-451 (Pubitemid 16104286)
47. Massignon D, Roullit S, Espinouse D, Coeur P (1989) Occurrence of a circulating anticoagulant, factor V inhibitor after surgical intervention. Ann Fr Anesth Reanim 81:70-72 (Pubitemid 19224936)
48. Okajima A, Horii J, Nasu K et al (1989) Factor V inhibitor with double cancer. Rinsho Ketsueki 30:514-519
49. Grigg AP, Dauer R, Thurlow PJ (1989) Bleeding due to an acquired inhibitor of platelet associated factor V. Aust NZ J Med 19:310-314 (Pubitemid 19263524)
50. Taillan B, Fuzibet JB, Vinti H et al (1989) Factor V inhibitor in celiac disease. Am J Med 87:360
51. Gordon B, Haire W, Duggan M, Langnas A (1991) Factor V inhibitor developing after liver transplantation in a 3-year-old child. Pediatrics 88:156-159
52. Buclin T, Schmidt PM, Hauert J, Winkel L, Chapuis G, Bachmann F (1992) Acquired factor V inhibitor treated with intravenous immunoglobulins. Schweiz Med Wochenschr 122:1968-1970 (Pubitemid 23016304)
53. Kapur A, Kelsey PR, Isaacs PET (1993) Factor V inhibitor in thrombosis. Am J Hematol 42:384-388 (Pubitemid 23104811)
54. Smid WM, de Wolf JTM, Nijland JH, Bom VJJ, van Der Meer J (1994) Sever bleeding caused by an inhibitor to coagulation factor V: a case report. Blood Coagul Fibrinolysis 5:133-137 (Pubitemid 24091329)
55. Denis A, Baudeau C, Verdy E, Couderc R, Rondeau E, Sraer JD (1995) Acquired circulating anticoagulant with anti-factor V activity in AIDS: first case report. Nouv Rev Fr Hematol 37:165-169
56. Tribl B, Knobl P, Derfler K et al (1995) Rapid elimination of a high-titer spontanoues factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression. Ann Hematol 71:199-203
57. George S, Nagabhushana MS, Cyran EM (1995) Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis. Am J Hematol 49:98-100
58. Suehisa E, Toku M, Akita N et al (1995) Study of an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid. Thromb Res 77:63-68
59. Fu YX, Kaufman R, Rudolph AE, Collum SE, Blinder MA (1996) Multimodality therapy of an acquired factor V inhibitor. Am J Hematol 51:315-318 (Pubitemid 26117545)
60. Brickner LA, Scannell KA, Sahud MA (1996) Acquired factor V inibito in a patient with acquired human immunodeficiency syndrome. Am J Hematol 52:332-333 (Pubitemid 26288757)
61. Van Spronsen DJ, Oosting JD, Hoffmann JJML, Breed WPM (1998) Factor V inhibitor associated with cold agglutinin disease. Ann Hematol 76:49-50 (Pubitemid 28058757)
62. Kamphuisen PW, Haan J, Rosekrans PCM, van der Meer FJM (1998) Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features. Am J Hematol 57:176-178 (Pubitemid 28096542)
63. Smith JD, Sindhi R, Rogers R, Lazarchick J (1998) Factor V inhibitor in a liver transplant patient associated with porcine xenoperfusion. Ann Clin Lab Sci 28:280-282 (Pubitemid 28440895)
64. Shastri KA, Ho C, Logue G (1999) An acquired factor V inhibitor: clinical and laboratory features. J Med 30:357-366 (Pubitemid 30366339)
65. Leroy-Matheron C, Mallat A, Duvoux C et al (1999) Inhibitor against coagulation factor V after liver transplantation. Transplantation 68:1054-1056
66. Jansen M, Schmaldienst S, Banyai S et al (2001) Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb). Br J Haematol 112:91-97 (Pubitemid 32151155)
67. Bayani N, Rugina M, Haddad-Vergnes L, Lelong F (2002) Hightiter acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors. Am J Hematol 71:33-36 (Pubitemid 34988583)
68. Takaku T, Kuriyama Y, Shoji N et al (2002) Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis. Rinsho Ketsueki 43:1050-1054
69. Kalafatis M, Simioni P, Tormene D, Beck DO, Luni S, Girolami A (2002) Isolation and characterization of an antifactor V antibody causino activated protein C resistance from a patient with severe thrombotic manifestations. Blood 99:3985-3992 (Pubitemid 35332038)
70. Hasegawa M, Tanaka T, Kii T et al (2003) Acquired inhibitor against coagulation factor V with severe hematuria. Rinsho Ketsueki 44:933-939
71. Okoshi Y, Akiyama H, Inoue T et al (2003) A long-lasting idiopathic factor V inhibitor. Rinsho Ketsueki 44:14-18
72. Ajzner E, Balogh I, Haramura G et al (2003) Anti-factor V autoantibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. J Thromb Haemost 1:943-999
73. de Raucourt E, Barbier C, Sinda P, Dib M, Peltier JY, Ternisien C (2003) High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. Am J Hematol 74:187-190 (Pubitemid 37363017)
74. Lian EC, Tzakis AG, Andrews D (2004) Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis. Am J Hematol 77:363-365 (Pubitemid 39578317)
75. Tukić L, Stamatović D, Tarabar O, Elez M, Zorić M, Mandić-Radić S (2005) Acquired factor V inhibitors in a polytraumatized patient. Vojnosanit Pregl 62:587-590
76. Godart B, Boinot C, Remblier C, Hajjar A, Beauchant M (2006) Acquired factor V inhibitor associated with valproic acid use in a cirrhotic patient. Gut 55:134-135 (Pubitemid 41820652)
77. Perdekamp MT, Rubenstein DA, Jesty J, Hultin MB (2006) Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assys. Blood Coagul Fibrinolysis 17:593-597 (Pubitemid 44434974)
78. Gacina P, Kusec R, Carzavec D, Raic B, Stancic V (2006) Acquired factor V inhibitor: a case report. Acta Clin Croat 45:199-201 (Pubitemid 44831772)
79. Endo H, Kawauchi K, Tomimatsu M et al. (2007) Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers. Intern Med 46:621-625 (Pubitemid 46845859)
80. Maughan EO, Wilson J, Wilde JT (2007) Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma. Int J Lab Hematol 29:316-319 (Pubitemid 47041486)
81. Milojkovic D, Patel R, Ford E, Arya R, Mufti G (2007) Acquired factor V inhibitor after hematopoietic stem cell transplantation. Thromb Haemost 98:685-687 (Pubitemid 47412899)
82. Shimizu I, Ichikawa N, Yotsumoto M, Sumi M, Ueno M, Kobayashi H (2008) High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors. Rinsho Ketsueki 49:413-416
83. Jeimy SB, Krakow EF, Fuller N, Tasneem S, Hayward CPM (2008) An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1. J Thromb Haemost 6:395-397
84. Lebrun A, Leroy-Matheron C, Arlet JB, Bartolucci P, Michel M (2008) Successful treatment with rituximab in a patient with an acquired factor V inhibitor. Am J Hematol 83:163-164
85. William BM (2008) Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor. Blood Coagul Fibrinolysis 19:327-328 (Pubitemid 351670422)
86. Gadelha T, Aquino JHW, Silva EA, Santos FL, de Oliveira MHFC (2008) The diversity in clinical presentation of acquired factor V inhibitor, two case reports. Acta Haematol 119:108-110 (Pubitemid 351591412)
87. Kindler S, Siegemund T, Fuhrer D, Petros S (2008) Thrombin generation assay in a patient with acquired factor V inhibitor. J Thromb Haemost 6:1985-1987
88. Shanmugam H, Jayaranee S, Eow GI (2010) A case report of an acquired inhibitor to coagulation factor V. Haemophilia [Epub ahead of print]
89. Tessier-Marteau A, Croquefer S, Meziani F, Cau S, Asfar P, Macchi L (2010) Acquired factor V inhibitor in a context of sepsis and disseminated intravascular coagulation. Am J Hematol 85:145-146
90. Franchini M, Lippi G (2010) Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Haemost 36:485-492
91. Yu Z, Lennon VA (1999) Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 340:227-228 (Pubitemid 29063222)